Hospital-acquired clostridium difficile infections: Estimating all-cause mortality and length of stay

Epidemiology

Volumn 25, Issue 4, 2014, Pages 570-575

  Lofgren, Eric T ^a   Cole, Stephen R ^a   Weber, David J ^a,b   Anderson, Deverick J ^c   Moehring, Rebekah W ^c  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONFIDENCE INTERVAL; FATALITY; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL TIME; UNITED STATES; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; PEPTOCLOSTRIDIUM DIFFICILE; RISK FACTOR; SOUTHEAST ASIA; STATISTICS AND NUMERICAL DATA; SURVIVAL;

AGED; ASIA, SOUTHEASTERN; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84902261365     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000119     Document Type: Article

References (16)

1. HCUPnet. Agency for Healthcare Research and Quality; 2006. Available at: http://hcupnet.ahrq.gov/. Accessed 17 September 2012.
2. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010;74:309-318.
3. McGlone SM, Bailey RR, Zimmer SM, et al. The economic burden of Clostridium difficile. Clin Microbiol Infect. 2012;18:282-289.
4. Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol. 2011;32:387-390.
5. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170:244-256.
6. Anderson DJ, Miller BA, Chen LF, et al. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network. Infect Control Hosp Epidemiol. 2011;32:315-322.
7. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK; Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007;28:140-145.
8. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656-664.
9. Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed. 2004;75:45-49.
10. Little, RJA, Rubin DB. The analysis of social science data with missing values. Sociol Method Res. 1989;18:292-326.
11. Lau B, Cole SR, Gange SJ. Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with timedependent hazards and delayed entry. Stat Med. 2011;30:654-665.
12. Cox DR. The analysis of exponentially distributed life-times with two types of failure. J R Stat Soc Ser B Stat Methodol. 1959;21:411-421.
13. Cole SR, Li R, Anastos K, et al. Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies. Stat Med. 2004;23: 3351-3363.
14. Checkley W, Brower RG, Muñoz A; NIH Acute Respiratory Distress Syndrome Network Investigators. Inference for mutually exclusive competing events through a mixture of generalized gamma distributions. Epidemiology. 2010;21:557-565.
15. Ghani AC , Donnelly CA, Cox DR, et al. Methods for estimating the case fatality ratio for a novel, emerging infectious disease. Am J Epidemiol. 2005;162:479-486.
16. Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol. 2010;31:21-27.